Methods & Compositions for the Activation of Gamma-delta T-cells IL
Country:
Israel
Docket No:
436313-000309
Publication Number:
260594
Patent Expiry:
01/13/2037
Claims Scope:
Patent issued May 1, 2021.
Sequence agnostic claims – Composition only.
Sequence agnostic claims targeting FDPS, further requiring a helper and envelope. Further claims to compositions (vectors and particles) that require 80%-95% sequence identity SEQ ID NOs: 1-4 (shRNA) and SEQ ID Nos: 5-10 (microRNA) that target FDPS. Combination claims also include amino bisphosphonates.
No limitation to activating GD T cells or infecting a cancer cell.